Lung cancer drug, Opdivo, approved for expanded use

March 4, 2015 6:46 PM

14 0

Posted by Staff on March 4, 2015 //

The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.

Read more

To category page